C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.
about
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharideAlginate microbeads are coagulation compatible, while alginate microcapsules activate coagulation secondary to complement or directly through FXII.Tissue factor expression on the surface of monocytes from a patient with hereditary angioedema.
P2860
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@en
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@nl
type
label
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@en
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@nl
prefLabel
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@en
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@nl
P2093
P2860
P356
P1476
C1-inhibitor efficiently inhib ...... tivation in human whole blood.
@en
P2093
D Christiansen
E W Nielsen
J K Ludviksen
O-L Brekke
P2860
P304
P356
10.1111/CEI.12098
P577
2013-08-01T00:00:00Z